Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review

C Zhao, KP Rakesh, L Ravidar, WY Fang… - European journal of …, 2019 - Elsevier
Sulfur (S VI) based moieties, especially, the sulfonyl or sulfonamide based analogues have
showed a variety of pharmacological properties, and its derivatives propose a high degree …

Chromone as a privileged scaffold in drug discovery: recent advances: miniperspective

J Reis, A Gaspar, N Milhazes… - Journal of medicinal …, 2017 - ACS Publications
The use of privileged structures in drug discovery has proven to be an effective strategy,
allowing the generation of innovative hits/leads and successful optimization processes …

Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review

WY Fang, L Ravindar, KP Rakesh… - European journal of …, 2019 - Elsevier
At present more than 250 FDA approved chlorine containing drugs were available in the
market and many pharmaceutically important drug candidates in pre-clinical trials. Thus, it is …

Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and …

AH Hasan, S Murugesan, SI Amran, S Chander… - Bioorganic …, 2022 - Elsevier
A series of around eight novel chalcone based coumarin derivatives (23a-h) was designed,
subjected to in-silico ADMET prediction, synthesized, characterized by IR, NMR, Mass …

Visible-light-induced surfactant-promoted sulfonylation of alkenes and alkynes with sulfonyl chloride by the formation of an EDA-complex with NaI in water at room …

L Lin, Z Yang, J Liu, J Wang, J Zheng, JL Li… - Green …, 2021 - pubs.rsc.org
A green and efficient visible-light-induced iodosulfonyl reaction of alkenes in water using an
EDA complex strategy at room temperature has been disclosed. The addition of a cationic …

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research

MJ Colwell, H Tagomori, S Chapman… - Translational …, 2022 - nature.com
Impaired cognition is often overlooked in the clinical management of depression, despite its
association with poor psychosocial functioning and reduced clinical engagement. There is …

Multi-targetable chalcone analogs to treat deadly Alzheimer's disease: Current view and upcoming advice

X Zhang, KP Rakesh, SNA Bukhari, M Balakrishna… - Bioorganic …, 2018 - Elsevier
The complications of Alzheimer's disease AD were deadly dangerous cause of
neurodegenerative disorders connected with the decline of the cognitive functions and loss …

G-protein-coupled receptors in CNS: a potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits

S Azam, ME Haque, M Jakaria, SH Jo, IS Kim, DK Choi - Cells, 2020 - mdpi.com
Neurodegenerative diseases are a large group of neurological disorders with diverse
etiological and pathological phenomena. However, current therapeutics rely mostly on …

[HTML][HTML] G protein-coupled receptors (GPCRs) in Alzheimer's disease: a focus on BACE1 related GPCRs

J Zhao, Y Deng, Z Jiang, H Qing - Frontiers in aging neuroscience, 2016 - frontiersin.org
The G protein coupled receptors (GPCRs) have been considered as one of the largest
families of validated drug targets, which involve in almost overall physiological functions and …

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches

V Asati, A Anant, P Patel, K Kaur, GD Gupta - European Journal of …, 2021 - Elsevier
Pyrazolopyrimidine scaffold is one of the privileged heterocycles in drug discovery. This
scaffold produced numerous biological activities in which anticancer is important one …